Injectable Production / Sterile process in Pharmaceutical industry l Interview Question & answers

Описание к видео Injectable Production / Sterile process in Pharmaceutical industry l Interview Question & answers

Injectable Production / Sterile manufacturing in Pharmaceutical industry l 30 Interview Question and answers
-----------------------------------------------------------------------------------------------
Go to below playlists and search for a topic you want:

1. QMS - Quality Management System in Pharmaceutical industry :    • QMS - Quality Management System in Ph...  
2. QA- Quality assurance in Pharmaceutical industry. :    • QA- Quality assurance in Pharmaceutic...  
3. QC - Quality Control in Pharmaceutical industry :    • QC - Quality Control in Pharmaceutica...  
4. OSD - Tablet Manufacturing in Pharmaceutical industry :    • OSD - Tablet Manufacturing in Pharmac...  
5. Injectable processing - Injectable processing or Sterile dosage formulation :    • Injectable processing - Injectable pr...  

-----------------------------------------------------------------------------------------------
Questions covered:
Q.: What is NVPC limit for GRADE A and Grade B ?
Q: What are the key steps involved in injection manufacturing ?
Q: Which are the important Qualification tests for Autoclave ?
Q: How are aseptic conditions maintained during injection manufacturing?
Q.: What is the difference between Sterile and Aseptic area ?
Q.: Why only 0.5 and 5 micron particles are measured for NVPC ?
Q: What is media fill testing, and why is it essential in injection manufacturing?
Q. : In which Area / class aseptic filling shall be carried out ?
Q: What are the critical environmental parameters monitored during injection manufacturing?
Q. : What are the important parameters of WFI as per USP?
Q: How is the container closure integrity of injections assessed?
Q: How is the container closure integrity of injections assessed?
Q.: Why nitrogen gas is used for purging and overlaying?
Q: What are the regulations and guidelines governing injection manufacturing?
Q. What are the basic types of filters used in pharmaceutical industry?
Q: How do you manage the risk of cross-contamination in multi-product facilities?
Q: Can you explain the role of container closure system integrity in injection manufacturing?
Q: What are the key considerations for selecting primary packaging materials for injectable products?
Q: How do you handle deviations and out-of-specification results during injection manufacturing?
Q: How do you ensure the stability of injectable products during manufacturing and storage?
Q. : Why three batches or three test cycles are considered for equipment Qualification ?
Q: What are the requirements for environmental monitoring in injection manufacturing facilities?
Q. : What is difference between Viable and Non-viable particle count ?
Q: How do you handle the disposal of rejected or expired injectable products?
Q. What are the significance of various zones for depyrogenation tunnel ?
Q.: Which are the commonly used methods for glove leak testing ?
Q. What is endotoxin and why depyrogentaion is important ?
Q. What are aseptic interventions ?
Q.: What is frequency for media fill ?
Q.: What are the important guidelines used for media fill ?
Q.: Why 0.2 micron filter is used for aseptic filtration in the pharmaceutical industry ?
-----------------------------------------------------------------------------------------------
Keywords to find this video:
process validation in pharmaceutical industry,pharmaceutical production,pharmaceutical,pharmaceutical industry,validation in pharmaceutical manufacturing,small scale pharmaceutical manufacturing in india,pharmaceutical industry in india,how to open pharmaceutical industry in india,future of pharmaceutical industry in india,pharma production interview,pharmaceutical manufacturing,injectable pharmaceutical,pharmaceutical production interview

-----------------------------------------------------------------------------------------------

Copyright disclaimer:
“Any illegal reproduction of this content will result in immediate legal action.”

Комментарии

Информация по комментариям в разработке